Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
8,337,406
-
Shares change
-
-417,272
-
Total reported value, excl. options
-
$148,034,944
-
Value change
-
-$7,922,344
-
Put/Call ratio
-
7.08%
-
Number of buys
-
23
-
Number of sells
-
-27
-
Price
-
$17.72
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q3 2021
75 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q3 2021.
AVITA Medical, Inc. - Common Stock (RCEL) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,337,406 shares
of 26,475,256 outstanding shares and own 31.49% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,571,353 shares), Redmile Group, LLC (1,346,217 shares), VANGUARD GROUP INC (1,261,948 shares), FARALLON CAPITAL MANAGEMENT LLC (800,000 shares), STATE STREET CORP (732,875 shares), Blackcrane Capital, LLC (434,171 shares), GEODE CAPITAL MANAGEMENT, LLC (419,601 shares), RTW INVESTMENTS, LP (280,000 shares), PURA VIDA INVESTMENTS, LLC (252,246 shares), and NORTHERN TRUST CORP (225,378 shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.